All content for New Retina Radio by Eyetube is the property of Retina Today and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
New Retina Radio is a place to hear stories about retina that are told nowhere else.
ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDR
New Retina Radio by Eyetube
33 minutes
2 months ago
ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDR
What role does mitochondrial dysfunction play in the pathogenesis of AMD? And could intervention change the course of early disease progression. David Lally, MD, shares results from the ReCLAIM-2 study, the phase 2 trial that assessed elamipretide (Stealth BioTherapeutics) in patients with non-central GA. What positive treatment effects were observed? And Ehsan Rahimy, MD, reviews findings from a retrospective analysis seeking to understand if continuous glucose monitoring could reduce the risk of NPDR progressing to more serious conditions. Listen in to learn what he and his colleagues found.
New Retina Radio by Eyetube
New Retina Radio is a place to hear stories about retina that are told nowhere else.
